was markedly reduced compared with isozyme A of normal mucosa. Heating of enzyme extracts at 50°C for 30 min before electrophoresis caused no change in the electrophoretic mobilities of any of the isozymes but slightly reduced their staining intensities. On the other hand, after heating at 55°C for 30 min, isozymes A and C were hardly detectable on subsequent staining. Incubation of enzyme extracts with neuraminidase at 37°C for 18 h caused no significant changes either in the mobility or in the staining reaction of any of these isozymes from normal and experimental tissuse. Isozymes A and C appeared to be soluble enzymes whereas isozyme B, due to its extraction in 0.2% Triton X-100, seemed to be bound to lysosomes. (Schein et al., Biochem. Pharmac., 1973 , 22, 2625 Chu and Lawley, Chem. Biol. Interactions, 1974, 8, 65) . Alkylated derivatives of nicotinamide cannot be utilized for the biosynthesis of NAD cofactors, essential for cell survival. Depletion of NAD in the liver occurs after pyrrolizidine alkaloids, dimethylnitrosamine, streptozotocin etc., and can be prevented by pretreatment with nicotinamide, which in some cases prevents also the cytotoxic effects.
More information is needed as regards the role of alkylated derivatives of nicotinamide in cell death and in relation to tumour induction. A relationship between carcinogenesis and mutagenesis was first suggested by T. Boveri in 1917 and K. H. Bauer in 1928 proposed the somatic mutation theory of cancer, although at that time the nature of the genetic material was unknown. The recognition of the biological role of DNA, following the elucidation of its structure by Crick and Watson in 1953, did not immediately revive the support for the mutation theory of cancer which had been under strong attack. This was mainly the result of the repeated failure to demonstrate mutation with such classic carcinogens as the polycyclic hydrocarbons and aromatic amines. Prior to 1940 polycyclic hydrocarbons were almost the only well studied group of carcinogens. During the subsequent 20 years, however, the number and variety of chemical substances both synthetic and naturally occurring, which were shown to induce cancer in animals, became so great that it seemed impossible to conceive of any common mechanism of tumour induction.
The breakthrough came with the recognition of the importance of metabolism in converting the applied carcinogen to the biologically active form. One class of carcinogen, namely the biological alkylating agents, did not require metabolic activation and a study of their mechanism of action had implicated DNA reaction. It seemed possible therefore that all carcinogens might act via electrophilic intermediates similar to those involved in alkylation and that these " ultimate carcinogens" might modify cellular DNA.
A great deal of evidence is now available which supports both the above postulates. In the case of the aromatic amines the identification of N-hydroxy metabolites by the Millers led to an understanding of
